Actavis facts for kids
 |
|
| Subsidiary | |
| Traded as | NYSE: ACT |
| Industry | Branded and generic pharmaceuticals, and pharmaceutical research and development |
| Fate | 2015 Irish tax inversion and merger with Allergan, Inc. |
| Successor | Allergan, plc |
| Founded | March 1984 in Libertyville, Illinois, United States |
| Founder | Allen Chao, Ph.D. and David Hsia, Ph.D. |
| Defunct | 2015 |
| Headquarters | Dublin, Ireland and Parsippany-Troy Hills, New Jersey, United States |
|
Number of locations
|
40 manufacturing facilities 27 global R&D centers |
|
Area served
|
≈100 countries |
|
Key people
|
Brenton L. Saunders (CEO and president) Paul Bisaro (executive chairman) |
| Products | Branded and generic pharmaceuticals |
| Revenue | US$13.062 billion (2014) |
|
Operating income
|
 US$1.090 billion (2014) |
 US$−1.63 billion (2014) |
|
| Total assets | US$6.881 billion (2014) |
| Total equity | US$28.335 billion (2014) |
|
Number of employees
|
21,600 (2015) |
| Parent | Teva Pharmaceuticals |
Actavis Generics is a big company that makes and sells different kinds of medicines. It used to be called Watson Pharmaceuticals and later Actavis plc. This company works all over the world, in about 100 countries.
Actavis Generics focuses on making:
- Branded medicines: These are new medicines with a specific brand name.
- Generic medicines: These are copies of branded medicines that are no longer protected by patents. They work the same but are often cheaper.
- Over-the-counter medicines: These are medicines you can buy without a doctor's prescription, like pain relievers.
- Biologic products: These are medicines made from living cells.
The company has main offices in Dublin, Ireland, and Parsippany-Troy Hills, New Jersey, United States.
Actavis PLC sells many well-known medicines. These include treatments for skin, brain, eye, and heart conditions. They also make medicines for women's health and stomach problems. Some of their products are Botox, Namenda, Restasis, and Linzess.
The company is one of the largest makers of generic medicines in the world. It is a top company in many global markets. Actavis also helps other companies sell generic medicines outside the US through its Medis business. Medis works with over 300 customers and offers more than 200 products. Actavis PLC is also working on new biologic medicines, with five currently being developed. The company has over 40 factories and distribution centers around the world. These can produce about 40 billion medicine units each year.
In June 2015, Actavis plc changed its name to Allergan plc. However, the company's generic medicine business in the U.S. and Canada still uses the Actavis name. In July 2015, Allergan PLC announced it would sell its Generics part, including Anda Inc, to Teva Pharmaceuticals for $40.5 billion. This sale was completed in early 2016.
Contents
Company History: How Actavis Generics Started
This company began in the spring of 1983. Two friends, Allen Chao, Ph.D. and David Hsia, Ph.D., used money from family and friends to start a small business. They wanted to develop new medicines.
Just two months later, they opened a small lab in Libertyville, Illinois, U.S. They had six employees, including themselves. Here, they started working on new products and testing them.
By the end of 1983, the company moved to Southern California. They set up in a larger space in Corona. This is where they began making generic medicines. The Corona location became the main office for the growing U.S. company.
How the Company Grew Over Time
Actavis has grown a lot, both by developing its own products and by buying other companies.
Growth in the 1990s
In 1993, Actavis, which was then called Watson, offered its shares to the public for the first time. This is called an Initial Public Offering (IPO). The company's shares were first listed on the NASDAQ stock exchange. In 1997, the company moved to the New York Stock Exchange (NYSE).
Growth from 2000 to 2009
In 2000, the company bought Schein Pharmaceutical Inc. This purchase more than doubled the size of the company. In the same year, the company made over $1 billion in sales.
In 2006, they bought Andrx Corporation. This made them the third-largest specialty medicine company based on how many prescriptions were filled. In 2007, Dr. Allen Chao, one of the founders, retired. Paul M. Bisaro took over as the new CEO.
The company started to grow internationally in 2009 when it bought the Arrow Group. This gave them a presence in over 20 countries. As part of this deal, they also acquired Eden Biodesign, a company that develops biologic medicines, in Liverpool, UK.
Growth from 2011 to 2014
In 2011, Watson moved its main office from Corona, California to Parsippany, New Jersey. The new office building was officially opened in June 2011.
Actavis Acquisition and Name Change
In November 2012, Watson bought a company called Actavis Group from Switzerland. This deal cost €4.25 billion. This made the combined company the third-largest generic medicine company in the world. It became a leader in important markets like the US, UK, Canada, and parts of Europe. After this purchase, Watson decided to use the Actavis name for all its global operations.
Warner Chilcott PLC Acquisition
On October 1, 2013, Actavis bought an Irish medicine company called Warner Chilcott PLC. This deal was worth about $8.5 billion. This merger created a company that expected to make about $10 billion in sales in 2013. It also became the third-largest specialty medicine company in the US. This company focused on women's health, urology, stomach issues, and skin conditions.
Because of this merger, the company moved its main headquarters to Ireland. This allowed them to take advantage of Ireland's lower corporate tax rate, which was 17% compared to 35% in the United States. This move inspired other drug companies to do similar things.
Forest Laboratories Acquisition
On July 1, 2014, Actavis announced that it had finished buying Forest Laboratories. This deal was worth about $25 billion. After this purchase, the company changed its leadership. Paul Bisaro became the Executive Chairman, and Brent Saunders became the new CEO and President.
Allergan Inc Acquisition and Actavis PLC Name Change
In November 2014, Actavis PLC announced its plan to buy Allergan Inc. Allergan is the company that makes Botox. On March 17, 2015, Actavis PLC completed the purchase of Allergan Inc for about $70.5 billion. This combination created a large global medicine company with sales of $23 billion and operations in 100 countries. In June 2015, Actavis PLC officially changed its name to Allergan PLC.
| Teva Pharmaceuticals |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Locations and Facilities
Main Offices Around the World
The main global office for Actavis Generics is in Dublin, Ireland. Its administrative office is in Parsippany, New Jersey, USA.
Where Medicines Are Made
The company has 40 factories in five different continents. These factories are very good at making different types of medicines. They make pills, patches, liquids, and injectable medicines. You can find these factories in many countries, including Belgium, Brazil, Canada, China, France, Germany, India, Ireland, and the United States.
Research and Development Centers
Actavis PLC also has 27 research and development (R&D) centers globally. These centers work on creating new and improved medicines. They focus on developing different forms of medicines, just like the manufacturing facilities. These R&D centers are located in countries such as Belgium, China, France, Iceland, Italy, India, Ireland, Japan, and the United States.
See also
In Spanish: Actavis para niños
